APA
Pfaller M. A., Messer S. A., Woosley L. N., Jones R. N. & Castanheira M. (20140121). Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. : Journal of clinical microbiology.
Chicago
Pfaller Michael A, Messer Shawn A, Woosley Leah N, Jones Ronald N and Castanheira Mariana. 20140121. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. : Journal of clinical microbiology.
Harvard
Pfaller M. A., Messer S. A., Woosley L. N., Jones R. N. and Castanheira M. (20140121). Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. : Journal of clinical microbiology.
MLA
Pfaller Michael A, Messer Shawn A, Woosley Leah N, Jones Ronald N and Castanheira Mariana. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. : Journal of clinical microbiology. 20140121.